Table 5.
Comparison of diagnostic matches for cytotechnologists and pathologists
| Diagnosis | Exact diagnosis match | Higher proportion | χ2 | P | |
|---|---|---|---|---|---|
| Cytotechnologist (%) | Pathologist (%) | ||||
| NILM | 91.6 | 85.2 | Cytotechnologist | 135.052 | <0.001 |
| ASC-US | 29.5 | 17.8 | Cytotechnologist | 4.256 | 0.039 |
| LSIL | 92.1 | 87.2 | Cytotechnologist | 45.220 | <0.001 |
| ASC-H | 22.2 | 24.0 | Pathologist | 0.035 | 0.851 |
| HSIL | 80.5 | 78.1 | Cytotechnologist | 6.057 | 0.014 |
| AGC | 21.0 | 24.6 | Pathologist | 0.380 | 0.538 |
| AIS | 48.8 | 43.8 | Cytotechnologist | 1.004 | 0.316 |
| Adenocarcinoma | 67.3 | 55.0 | Cytotechnologist | 17.703 | <0.001 |
| Squamous cell carcinoma | 64.6 | 59.3 | Cytotechnologist | 2.935 | 0.087 |
| Total | 85.0 | 79.8 | Cytotechnologist | 135.599 | <0.001 |
NILM: Negative for intraepithelial lesion or malignancy, ASC-US: Atypical squamous cells of undetermined significance, LSIL: Low-grade squamous intraepithelial lesion, ASC-H: Atypical squamous cells cannot exclude high grade, HSIL: High-grade squamous intraepithelial lesion, AGC: Atypical glandular cells, AIS: Adenocarcinoma in situ